Here are clinical trials that currently enrolling participants.
The MK-7264-042 study is enrolling women who leak urine when they cough. This condition is known as chronic cough induced stress urinary incontinence, or cSUI. The MK-7264-042 clinical research study is evaluating an investigational drug to see if it may be a safe and effective treatment for cSUI.Visit Website
If you experience chronic cough, activites you once took for granted can become challenges. The MK-7264-043 clinical research study is evaluating an investigational drug to see if it may be a safe and effective treatment for chronic cough.Visit Website
If you have narcolepsy, you may be able to help with research to develop a new treatment option. People with narcolepsy need more options for dealing with the symptoms that can dominate their lives. Clinical studies are essential components of the research to investigate new treatment options, and you may be able to help.Visit Website
Endometriosis can be a painful and debilitating condition and is often frustrating for women who are living with it, in part because others don’t understand the effect it can have on daily life and the treatments to relieve symptoms may have varying results. The Edelweiss study is assessing the safety and effectiveness of an investigational drug alone and in combination with hormonal add-back therapy compared to placebo in women with moderate to severe pain associated with endometriosis.Visit Website
The intrigue study is testing the investigational drug DCC-2618 as a potential new treatment option for patients living with gastrointestinal stromal tumors (GIST). The study is being done to learn more about the safety of DCC-2618 and how well it works against cancer, as compared to Sutent® (sunitinib), in patients who have previously received imatinib.Visit Website
More convenient therapy is the BASIS of our research. The BASIS study is testing an investigational subcutaneous (under the skin) injection for people with severe hemophilia. This study drug works with tissue factor replacement to potentially reduce bleeding episodes in hemophilia patients with and without inhibitors.Visit Website
The LEAGUE Study is looking at an investigational drug for ADHD. The investigational drug being evaluated is a nonstimulant but has a different mechanism of action to previous ADHD treatmentsVisit Website
Make a difference for yourself and others. Work with researchers and participants to gain access to the latest treatments. Sign up to be notified when there are studies for your condition or a loved one in your location. Participants of all backgrounds are needed as some conditions are more prevalent within certain populations. Whatever your age, gender, race or background – clinical trials need YOU!